Benzinga··Bamboo WorksNovel Gastric Drug Powers Hong Kong IPO: TenNor Therapeutics Surges 179% on Debut
TenNor Therapeutics surged 179% on Hong Kong IPO debut, raising $76 million on 9,000x oversubscription, fueled by enthusiasm for its novel gastric drug targeting helicobacter pylori infections.
WUXAYclinical-stagebiotech IPO